Treatment of MH Disorders with Ketamine in Aga Khan University Hospital
Starting on:
Jun 29, 2023
Ending on:
Jun 29, 2023
Moderator(s):
Dr. Catherine Gitau
Dr Catherine Gitau Consultant Psychiatrist & Section Head Psychiatry Department of Medicine Aga Khan University Hospital Qualifications MBBS(IMTU) 2005 Mmed Psychiatry (UON) 2013 Areas of Interest Management of mental illnesses using evidence-based pharmacological, psychological and physical treatments Integration of mental healthcare at all levels of healthcare provision Suicide prevention and psychosocial interventions to enhance mental well-being. Addiction Treatment and relapse prevention Mental health research
Venue:
Virtual Zoom Webinar
Max Credits:
3 Points

Provider:
Kenya Psychiatrists Association
Claim Points

Treatment of MH Disorders with Ketamine in Aga Khan University Hospital

Starting on:
Jun 29, 2023
Ending on:
Jun 29, 2023
Venue:
Virtual Zoom Webinar

Description

Treatment of MH Disorders with Ketamine in Aga Khan University Hospital

Objectives

Educate healthcare professionals: Provide participants with a comprehensive understanding of the role of ketamine in the treatment of mental health disorders, including its mechanism of action, efficacy, safety considerations, and potential benefits. Increase awareness and knowledge: Enhance participants' knowledge about the use of ketamine as a therapeutic option for specific mental health disorders such as treatment-resistant depression, post-traumatic stress disorder (PTSD), bipolar disorder, and others. Discuss research findings and evidence: Review the latest research and clinical evidence supporting the use of ketamine in mental health treatment, including both the positive outcomes and potential limitations or challenges. Explore treatment protocols and guidelines: Share information on the appropriate administration, dosage, and monitoring protocols for ketamine therapy, as well as guidelines for patient selection, evaluation, and follow-up care. Address safety and ethical considerations: Discuss the potential side effects, risks, and precautions associated with ketamine treatment, emphasizing the importance of patient safety and ethical considerations in its use.

Presenters

  1. Dr. Alphonce Nabiswa
    Consultant Psychiatrist

Search For CPD Activity